OncoSec Medical Advancing Inovio’s Technology Against CancerBruce V. Bigelow2/8/12OncoSec Medical CEO Punit Dhillon tells me the startup he helped establish in San Diego last March is beginning mid-stage safety and efficacy trials of its proprietary technology for enhancing drug delivery in treatments of several types of skin cancer.The technology, which OncoSec acquired from Blue Bell, PA-based Inovio Pharmaceuticals (AMEX: INO) almost a year ago, transmits intense electrical pulses into skin tumors through six electrode needles that are pushed into the skin.
OncoSec Medical Advancing Inovio's Technology Against Cancer …
Sursa:
OncoSec Medical Advancing Inovio's Technology Against Cancer …